Skip to content

Multimodal Retinal Imaging of Cerebrovascular Stroke

Multimodal Retinal Imaging of Cerebrovascular Stroke

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03964610
Acronym
OCTAV
Enrollment
62
Registered
2019-05-28
Start date
2019-11-15
Completion date
2022-02-15
Last updated
2022-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular Accidents, Stroke

Keywords

optical coherence tomography (OCT-A), color fundus photography (CFP), Retinal microvascularization, Cerebral microangiopathy

Brief summary

The hypothesis is that in patients with stroke, abnormalities of retinal microvascularization shown on color fundus photography and the depletion of retinal capillary density evaluated by OCT-A are markers of acute impairment of microcirculation of the central nervous system and are correlated with lesions on brain imaging. Patients hospitalized for stroke MRI-confirmed, will be included. An ophthalmologic assessment including color fundus photography (CFP) and OCT-A will be carried out after stabilization and at 3 months follow-up. Outcomes assessor will be blinded.

Interventions

DIAGNOSTIC_TESTcolor fundus photography (CFP) and OCT-A

Included patients will have an ophthalmologic assessment (OCT-A and CPF) after stabilization and at 3 months follow-up.

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Acute ischemic stroke * With cerebral microangiopathy (defined by a SVD score \> 1)

Exclusion criteria

* Acute hemorrhagic stroke * Anophthalmia

Design outcomes

Primary

MeasureTime frame
Presence of an anomaly in color fundus photography or an anomaly of retinal capillary density to OCT-A3 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026